GlobalData
GlobalData

Media

The FT, Sky News, Bloomberg, WSJ, along with over 77 other leading press organisations worldwide quote our data and insight and consider us a trusted, independent source.

OpenAI acquisition of Rockset to enhance AI capabilities evokes optimism among X influencers, finds GlobalData

OpenAI, an artificial intelligence (AI) research lab backed by Microsoft, has acquired Rockset, a company that specialises in real-time analytics databases, for almost US$200 million. The acquisition has drawn attention and various reactions from influencers on social media platform “X”, reveals the Social Media Analytics Platform of GlobalData, a leading data and analytics company. Smitarani […]
Read more

Bayer’s BAY2927088 to face intense competition in EGFR-mutant but limited competition in HER2-exon 20 mutant NSCLC market in China, says GlobalData

Bayer AG’s BAY2927088 recently received the Breakthrough Therapy designation from the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA) in China. Following approval, BAY2927088 is expected to face intense competition in the epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer (NSCLC) but limited competition in the human epidermal growth factor […]
Read more

Mental wellbeing top concern for nearly three quarters of consumers globally, urging insurers to prioritize mental health support, says GlobalData

Concerning levels of mental wellbeing have been identified among selected countries, underscoring the need for intervention and attention in this critical area. This emphasizes the role of insurers and employers in addressing these concerns to enhance overall consumer wellbeing. Nearly three quarters of consumers globally see mental wellbeing as their top concern, according to a […]
Read more

Vertex could solidify dominance in cystic fibrosis market with vanza triple approval, says GlobalData

With the submission of regulatory marketing applications for its once-daily vanzacaftor triple, also known as the vanza triple program (vanzacaftor/tezacaftor/deutivacaftor) with the European Medicines Agency (EMA) and the US FDA, Vertex Pharmaceuticals is expected to hold its lead in the development of therapies for the treatment of cystic fibrosis (CF). Approval and success of vanza […]
Read more

Prachand LCH procurement to propel India’s quest for indigenization of defense manufacturing, says GlobalData

The Indian Ministry of Defence (MoD) issued a Request for Proposal (RFP) to Hindustan Aeronautics Limited (HAL) for the acquisition of 156 Prachand Light Combat Helicopters (LCH), which will cost the country’s exchequer about $5.4 billion. This procurement holds paramount importance in India’s quest for self-reliance in defense manufacturing and is expected to boost the […]
Read more

US startups raise over $50 billion VC funding during Jan-May 2024 despite decline in deal volume, reveals GlobalData

The US startups secured $52.6 billion venture capital (VC) funding through 1,985 deals in the first five months of 2024. Despite a significant year-on-year (YoY) decline in deal volume, the funding value dropped only slightly, highlighting a trend of larger investments in fewer deals. Notably, May saw a surge with four billion-dollar deals, emphasizing cautious […]
Read more

MQ-4C Triton to improve Australia’s maritime surveillance capabilities and facilitate long-range targeting, says GlobalData

Australia recently received its first MQ-4C Triton from the US, marking a significant achievement in stepping up the Royal Australian Air Force’s (RAAF) maritime surveillance and intelligence-gathering capabilities in the tense Indo-Pacific region. This high-altitude long endurance (HALE)-category UAV would enable RAAF to achieve increased situational awareness over larger areas of Australia’s maritime borders and […]
Read more
1 130 131 132 133 134 776